Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.73%39.13B | 2.83%148.26B | 3.71%35.53B | 1.62%39.41B | 2.21%36.3B | 3.91%37.01B | 4.87%144.18B | 9.82%34.26B | 11.58%38.78B | 16.20%35.52B |
Cost of revenue | -2.52%12.64B | -10.26%50.23B | -13.43%11.62B | -8.73%13.29B | -12.13%12.36B | -6.94%12.96B | 11.53%55.98B | 5.94%13.42B | 9.79%14.56B | 23.84%14.06B |
Gross profit | 10.16%26.49B | 11.14%98.02B | 14.76%23.91B | 7.85%26.12B | 11.60%23.94B | 10.88%24.05B | 1.03%88.2B | 12.47%20.83B | 12.68%24.22B | 11.69%21.45B |
Operating expense | 19.63%15.42B | 11.31%64.72B | 12.21%21.06B | 7.51%16.55B | 13.22%14.23B | 12.90%12.89B | 6.99%58.15B | 17.85%18.77B | 18.87%15.39B | -9.97%12.57B |
Selling and administrative expenses | 9.54%9.22B | 0.42%34.96B | -8.01%9.22B | 3.30%8.79B | 5.58%8.53B | 2.66%8.42B | 8.20%34.81B | 12.17%10.02B | 8.26%8.51B | 4.99%8.08B |
-General and administrative expense | 9.54%9.22B | 0.42%34.96B | -8.01%9.22B | 3.30%8.79B | 5.58%8.53B | 2.66%8.42B | 8.20%34.81B | 12.17%10.02B | 8.26%8.51B | 4.99%8.08B |
Research and development costs | 26.83%7.5B | 31.25%31.68B | 35.29%12.18B | 28.29%6.98B | 33.35%6.61B | 24.76%5.91B | 5.56%24.14B | 22.92%9B | 0.37%5.44B | -22.37%4.95B |
Other operating expenses | 58.14%204M | 13.20%1.25B | 471.52%943M | -41.39%967M | -83.50%113M | 0.78%129M | 25.40%1.11B | -55.76%165M | 876.33%1.65B | 500.88%685M |
Total other operating income | -4.13%1.51B | 65.78%3.16B | 206.73%1.28B | -8.61%191M | -11.27%1.02B | -4.84%1.57B | 21.30%1.91B | -40.74%416M | -58.37%209M | 394.85%1.15B |
Operating profit | -0.76%11.08B | 10.81%33.3B | 38.02%2.85B | 8.45%9.57B | 9.32%9.71B | 8.64%11.16B | -8.80%30.05B | -20.54%2.06B | 3.31%8.83B | 69.29%8.89B |
Net non-operating interest income (expenses) | 19.86%332M | -26.88%321M | -5,125.00%-201M | 28.93%254M | -800.00%-9M | 16.39%277M | 24.36%439M | 123.53%4M | 15.20%197M | 92.86%-1M |
Non-operating interest income | 21.81%363M | 13.04%650M | -7.14%39M | 21.28%285M | -12.90%27M | 12.03%298M | 21.82%575M | 110.00%42M | 14.63%235M | 181.82%31M |
Non-operating interest expense | 47.62%31M | 141.91%329M | 531.58%240M | -18.42%31M | 12.50%36M | -25.00%21M | 14.29%136M | 2.70%38M | 11.76%38M | 28.00%32M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -0.25%11.41B | 10.26%33.62B | 27.87%2.64B | 8.90%9.83B | 9.24%9.71B | 8.81%11.44B | -8.44%30.49B | -19.85%2.07B | 3.52%9.02B | 69.67%8.88B |
Income tax | -57.55%1.14B | 1.21%7.76B | -58.82%794M | 27.32%2B | 19.37%2.28B | 18.94%2.69B | -7.64%7.67B | 195.25%1.93B | -27.65%1.57B | 46.58%1.91B |
Net income | 17.36%10.27B | 13.30%25.85B | 1,239.86%1.85B | 5.02%7.83B | 6.47%7.43B | 6.03%8.75B | -8.72%22.82B | -92.83%138M | 13.87%7.45B | 77.37%6.97B |
Net income continuous operations | 17.34%10.27B | 13.30%25.85B | 1,230.22%1.85B | 5.02%7.83B | 6.47%7.43B | 6.03%8.75B | -8.71%22.82B | -92.78%139M | 13.86%7.45B | 77.32%6.97B |
Noncontrolling interests | 150.00%5M | -71.43%2M | 1M | 0 | -200.00%-1M | -50.00%2M | -41.67%7M | 0 | -50.00%1M | 0.00%1M |
Net income attributable to the company | 17.32%10.26B | 13.32%25.85B | 1,239.86%1.85B | 5.02%7.83B | 6.51%7.43B | 6.06%8.75B | -8.70%22.81B | -92.83%138M | 13.91%7.45B | 77.40%6.97B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 17.32%10.26B | 13.32%25.85B | 1,239.86%1.85B | 5.02%7.83B | 6.51%7.43B | 6.06%8.75B | -8.70%22.81B | -92.83%138M | 13.91%7.45B | 77.40%6.97B |
Gross dividend payment | ||||||||||
Basic earnings per share | 17.31%152.4 | 13.32%383.82 | 1,239.02%27.45 | 5.03%116.2 | 6.50%110.26 | 6.07%129.91 | -8.70%338.7 | -92.82%2.05 | 13.90%110.64 | 77.43%103.53 |
Diluted earnings per share | 17.31%152.4 | 13.32%383.82 | 1,239.75%27.45 | 5.03%116.2 | 6.50%110.26 | 6.07%129.91 | -8.70%338.7 | -92.83%2.0489 | 13.90%110.64 | 77.43%103.53 |
Dividend per share | 0 | 8.77%124 | 8.77%62 | 0 | 8.77%62 | 0 | 3.64%114 | -3.39%57 | 0 | 11.76%57 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |